Well, archer, I don't know about "good" drama, and we could all do without it, I'm sure. But, NOTHING is wrong with the product(s) ... this, too, shall pass! And, when it does, we can kiss our D-list bashers good-bye!!
Awww...volstate, don't be a hater! Didn't say I had a huge position ... just enough to put a big smile on my face when I opened up my account after the long weekend! It could happen to you, too, but karma is a #$%$, so be careful!
So, a "criminal" investigation results in giving back essentially last weeks' gains on paltry volume? Oooh, scary! I'll take some of my CPXX gains and add a few this summer while we wait for updated #s. (For those naysayers ... go ahead and check the CPXX board postings over the past couple of months if you doubt that I owned it!!) Next up on the buyout list will be CEMP!! I can wait for OSIR to clear things up! Risk/reward is not on our friendly shorts' side if recent news couldn't take it down. You're wasting your collective MDXG breath!
And at the high of the day, it seems there were lots of sellers? Damned computers!!
How do 200K+ shares trade in the thin a/h market and not move the needle? Prearranged? All 200K traded were at 5.55 and 5.56. Interesting!
Amarin Announces FDA New Chemical Entity Market Exclusivity Determination for Vascepa(R) (icosapent ethyl) Capsules
Amarin Corp. Plc
1 minute ago
BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - May 31, 2016) - Amarin Corporation plc (AMRN) announced today that the U.S. Food and Drug Administration (FDA) has determined that Vascepa® (icosapent ethyl) capsules are eligible for five-year, new chemical entity (NCE), marketing exclusivity pursuant to the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act. This determination provides Vascepa with the benefits of NCE exclusivity afforded by statute. NCE exclusivity for Vascepa runs from its date of FDA approval on July 26, 2012 and extends until July 26, 2017. The statutory 30-month stay triggered by patent litigation following generic application submissions permitted on July 26, 2016 would expire on January 26, 2020, seven-and-a-half years from FDA approval.
"Amarin's goal is to protect the commercial potential of Vascepa to 2030," stated John F. Thero, president and chief executive officer of Amarin. "NCE regulatory exclusivity complements multiple patents covering Vascepa with expiration dates in 2030."
Just holding and buying a few trading shares on the exaggerated dips! It's far from done!! Consolidating a bit!!
So...where did the MMs get those 100K plus shares being traded in the last 5 minutes with no effect on the pps? Sheesh! Can you say "quiet accumulation"?
Well, IF that is true, we all know they run it up before an offering! Still a good risk-reward at current levels, imo. AND ... always a possibility of a partnership!
Sure hope they don't get a takeover offer ... the last two up and coming antibiotic stocks I owned, did. And, they both went too cheap!!
"Somebody" keeps throwing 10K+ on the ask at $5.33 and then removes it when this retreats under $5.30. More "spoofing" by HFT! SEC is toothless!
are all, coincidentally, 3 months or less old. I wonder why they weren't screaming their prophetic prognostications from the roof tops when OSIR was in the $20's? They're no better than the ambulance chasing lawyers that follow biotech bad news around like a dog after a pork chop! Amazing that they all managed to find each other about the same period in time and also have such a collectively myopic view of OSIR and their technology, all the while having such an in depth knowledge of their corporate governance! I call B.S.
Nah...if they really wanted it to break down, they would dump a bunch on a weak underlying bid. We've seen it a million times here ... this is acting very cagey this week. IF "they" tank it, you simply either be ready to pick up some shares or keep a bid in wherever you want to buy. Works EVERY time. You don't chase TROV, but you sure as heck buy the dips!!
Have a good weekend, all!
Well frozen, I'm too polite to express what YOU sound like. "Rookie"? Hardly! As for the rest of your rant, I'm willing to see how it all plays out without the need to post repetitive rants on a message board 24/7.
Wendy, "you ignorant #$%$" ... We've got lower and lower volume ... a few hundred shares moves this around in .10-.20 increments. Who knows what puppetmaster makes this move around right now. It might even be your little group of miscreants, for all I know. I guess critical thinking isn't your strong suit ...
btw ... the name calling was a SNL reference only used to point out how personal attacks are really uncalled for.
Doomsday posters better get a new schtick ... they're not scaring up enough shares. Doesn't look like many shares are being "dumped" by worried investors! Laughable ... there's no REAL selling going on at these levels. This is tightly held and being accumulated by existing institutional holders. Yawn ...